| 000 | 01694 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250513212409.0 | ||
| 264 | 0 | _c20000614 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0146-0404 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNiemelä, M | |
| 245 | 0 | 0 |
_aHemangioblastomas of the retina: impact of von Hippel-Lindau disease. _h[electronic resource] |
| 260 |
_bInvestigative ophthalmology & visual science _cJun 2000 |
||
| 300 |
_a1909-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFinland _xepidemiology |
| 650 | 0 | 4 | _aFluorescein Angiography |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHemangioblastoma _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLigases |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPedigree |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProteins _xgenetics |
| 650 | 0 | 4 |
_aRetinal Neoplasms _xcomplications |
| 650 | 0 | 4 | _aTumor Suppressor Proteins |
| 650 | 0 | 4 | _aUbiquitin-Protein Ligases |
| 650 | 0 | 4 | _aVisual Acuity |
| 650 | 0 | 4 | _aVon Hippel-Lindau Tumor Suppressor Protein |
| 650 | 0 | 4 |
_avon Hippel-Lindau Disease _xcomplications |
| 700 | 1 | _aLemeta, S | |
| 700 | 1 | _aSainio, M | |
| 700 | 1 | _aRauma, S | |
| 700 | 1 | _aPukkala, E | |
| 700 | 1 | _aKere, J | |
| 700 | 1 | _aBöhling, T | |
| 700 | 1 | _aLaatikainen, L | |
| 700 | 1 | _aJääskeläinen, J | |
| 700 | 1 | _aSummanen, P | |
| 773 | 0 |
_tInvestigative ophthalmology & visual science _gvol. 41 _gno. 7 _gp. 1909-15 |
|
| 999 |
_c10796882 _d10796882 |
||